相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8+T cells and an infiltration pattern that resembles ulcerative colitis
Sara Hone Lopez et al.
VIRCHOWS ARCHIV (2021)
Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature
Weixun Zhou et al.
GASTROENTEROLOGY RESEARCH (2018)
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
Jae-Ki Choi et al.
INFECTION AND CHEMOTHERAPY (2018)
Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients
Satoshi Nishiwaki et al.
BLOOD (2017)
A Case of Dasatinib-Induced Hemorrhagic Colitis Diagnosed by the Lymphocyte Transformation Test in a Chronic Myeloid Leukemia Patient
Hongkeun Ahn et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
A Case of Dasatinib-Induced Hemorrhagic Colitis Diagnosed by the Lymphocyte Transformation Test in a Chronic Myeloid Leukemia Patient
Hongkeun Ahn et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature
Mohamed Shanshal et al.
ACTA HAEMATOLOGICA (2016)
Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ibrahim Aldoss et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial
Jorge E. Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
The histopathological approach to inflammatory bowel disease: a practice guide
Cord Langner et al.
VIRCHOWS ARCHIV (2014)
The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
Benoit Chassaing et al.
GASTROENTEROLOGY (2011)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)